4//SEC Filing
Edwards Lifesciences Corp 4
Accession 0001225208-17-009815
$EWCIK 0001099800operating
Filed
May 14, 8:00 PM ET
Accepted
May 15, 6:34 PM ET
Size
11.0 KB
Accession
0001225208-17-009815
Insider Transaction Report
Form 4
Verguet Patrick B
CVP, Europe
Transactions
- Exercise/Conversion
Common Stock
2017-05-12$44.62/sh+7,000$312,305→ 145,268.15 total - Sale
Common Stock
2017-05-12$110.68/sh−7,000$774,732→ 138,268.15 total - Sale
Common Stock
2017-05-15$113.13/sh−1,900$214,947→ 136,368.15 total - Sale
Common Stock
2017-05-15$113.13/sh−2,600$294,148→ 133,768.15 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2017-05-12−7,000→ 66,800 totalExercise: $44.62From: 2012-05-12Exp: 2018-05-11→ Common Stock (7,000 underlying)
Footnotes (1)
- [F1]This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001099800
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 6:34 PM ET
- Size
- 11.0 KB